Drug Interactions between eravacycline and mannitol / sorbitol topical
This report displays the potential drug interactions for the following 2 drugs:
- eravacycline
- mannitol/sorbitol topical
Interactions between your drugs
mannitol eravacycline
Applies to: mannitol / sorbitol topical and eravacycline
MONITOR: The coadministration of diuretics with tetracyclines may result in decreased renal function and abnormalities in electrolytes and acid-base balance. As a class, tetracyclines can cause anti-anabolic effects which have led to increased blood urea nitrogen (BUN), azotemia, acidosis, and hyperphosphatemia. Diuretics have the potential to cause electrolyte and metabolic abnormalities, as well as worsen renal function. When used together, it is possible that these two classes of medications could have additive adverse effects.
MANAGEMENT: Patients on concomitant therapy with tetracycline antibiotics and diuretics should have their renal function and electrolytes monitored closely. The risk of additive adverse effects on the patient's renal function, electrolytes, and acid-base balance differs depending on the type of diuretic being used, the specific tetracycline antibiotic, and the clinical status of the patient. The manufacturer's labeling should be consulted for more specific recommendations.
References (12)
- Jick H, Slone D, Shapiro S, et al. (1972) "Tetracycline and drug-attributed rises in blood urea nitrogen: a report from the Boston Collaborative Drug Surveillance Program." JAMA, 220, p. 377-9
- Garty M, Hurwitz A (1980) "Effect of cimetidine and antacids on gastrointestinal absorption of tetracycline." Clin Pharmacol Ther, 28, p. 203-7
- Tannenberg AM (1972) "Tetracycline and rises in urea nitrogen." JAMA, 221, p. 713
- Alexander MR (1972) "Tetracycline and rises in urea nitrogen." JAMA, 221, p. 713-4
- (2022) "Product Information. Xerava (eravacycline)." PAION Deutschland GmbH
- (2021) "Product Information. Xerava (eravacycline)." Tetraphase Pharmaceuticals, Inc
- (2022) "Product Information. Ospolot (sulthiame)." Phebra Pty Ltd, 10
- (2022) "Product Information. AcetaZOLAMIDE (acetaZOLAMIDE)." Mylan Institutional (formerly UDL Laboratories)
- (2021) "Product Information. AMILoride Hydrochloride (aMILoride)." Padagis
- (2020) "Product Information. Spironolactone (spironolactone)." Amneal Pharmaceuticals
- (2022) "Product Information. Kerendia (finerenone)." Bayer Pharmaceutical Inc
- (2021) "Product Information. Eplerenone (eplerenone)." Westminster Pharmaceuticals LLC
Drug and food interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.